Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Invested Capital (2017 - 2025)

Selectis Health's Invested Capital history spans 13 years, with the latest figure at $12.9 million for Q3 2025.

  • For Q3 2025, Invested Capital rose 62.22% year-over-year to $12.9 million; the TTM value through Sep 2025 reached $12.9 million, up 62.22%, while the annual FY2024 figure was $13.7 million, 38.22% down from the prior year.
  • Invested Capital for Q3 2025 was $12.9 million at Selectis Health, up from $12.3 million in the prior quarter.
  • Across five years, Invested Capital topped out at $22.2 million in Q4 2023 and bottomed at $3.2 million in Q4 2022.
  • The 5-year median for Invested Capital is $9.4 million (2021), against an average of $10.2 million.
  • The largest annual shift saw Invested Capital plummeted 90.57% in 2021 before it surged 583.54% in 2023.
  • A 5-year view of Invested Capital shows it stood at $9.4 million in 2021, then tumbled by 65.48% to $3.2 million in 2022, then soared by 583.54% to $22.2 million in 2023, then tumbled by 38.22% to $13.7 million in 2024, then dropped by 6.28% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Invested Capital are $12.9 million (Q3 2025), $12.3 million (Q2 2025), and $12.9 million (Q1 2025).